MAI Capital Management’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111K | Sell |
48,238
-58,559
| -55% | -$135K | ﹤0.01% | 1362 |
|
|
2025
Q1 | $834K | Buy |
106,797
+6,030
| +6% | +$47.1K | 0.01% | 657 |
|
|
2024
Q4 | $471K | Sell |
100,767
-59,991
| -37% | -$280K | ﹤0.01% | 831 |
|
|
2024
Q3 | $866K | Buy |
160,758
+176
| +0.1% | +$949 | 0.01% | 577 |
|
|
2024
Q2 | $1.42M | Sell |
160,582
-20,828
| -11% | -$184K | 0.01% | 488 |
|
|
2024
Q1 | $2.13M | Buy |
181,410
+83,398
| +85% | +$980K | 0.02% | 384 |
|
|
2023
Q4 | $1.1M | Buy |
98,012
+602
| +0.6% | +$6.78K | 0.01% | 430 |
|
|
2023
Q3 | $659K | Buy |
97,410
+38,233
| +65% | +$259K | 0.01% | 532 |
|
|
2023
Q2 | $537K | Buy |
59,177
+39,534
| +201% | +$359K | 0.01% | 600 |
|
|
2023
Q1 | $127K | Buy |
+19,643
| New | +$127K | ﹤0.01% | 953 |
|